BioXcel Therapeutics, Inc. (BTAI) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -11.81M | -14.21M | -18.79M | -12.57M | -12.04M | -14.81M | -16.34M | -23.17M | -17.71M | -26.86M | -37.58M | -38.21M |
| Operating CF Margin % | -5732.52% | -5550.78% | -19170.41% | -10479.17% | -7168.45% | -4046.17% | -7634.58% | -2099.09% | -3042.27% | -7144.41% | -11021.7% | -8360.18% |
| Operating CF Growth % | 1.94% | 4.04% | -14.99% | 45.74% | 31.98% | 44.87% | 56.53% | 39.34% | 66.18% | 30.48% | -20.52% | -15.42% |
| Net Income | -12.69M | -12.54M | -30.91M | -19.19M | -7.25M | -10.86M | -13.65M | -8.3M | -26.79M | -22.26M | -50.49M | -53.52M |
| Depreciation & Amortization | 58K | 74K | 75K | 75K | 76K | 77K | 77K | 77K | 78K | 78K | 79K | 153K |
| Stock-Based Compensation | 435K | 450K | 581K | 1.56M | 180K | 0 | 1.86M | 1.06M | 3.43M | 3.6M | 4.01M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -961K | -1.26M | 13.06M | 2.58M | -3.46M | -472K | -3.31M | -10.59M | 1.3M | 1.13M | 862K | 6.41M |
| Working Capital Changes | 1.35M | -928K | -1.6M | 2.4M | -1.58M | -3.56M | -1.32M | -5.42M | 4.27M | -9.41M | 7.95M | 8.75M |
| Change in Receivables | 17K | -233K | 17K | -17K | 131K | -128K | 809K | -434K | -307K | 664K | -304K | -148K |
| Change in Inventory | 222K | -263K | 47K | 136K | 37K | 846K | 1.16M | -241K | -448K | 27K | -93K | 27K |
| Change in Payables | 2.21M | 8.01M | -1.08M | 2.31M | -2.27M | -3.33M | -1.66M | -4.16M | 4.83M | -12.32M | 7.25M | 6.5M |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | 4.38% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 232K | 5.65M | 37.53M | 137K | 13.2M | 4.28M | 454K | 5.3M | 26.63M | 2.12M | 0 | 250K |
| Debt Issued (Net) | -8.11M | 0 | 0 | 0 | 0 | -2.5M | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 8.34M | 5.65M | 37.55M | 140K | 14.01M | 6.82M | 468K | 5.48M | 26.74M | 2.38M | 0 | 250K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -16K | -3K | -804K | -46K | -14K | -172K | -117K | -252K | 0 | 0 |
| Net Change in Cash | -11.58M | -8.56M | 18.75M | -12.44M | 1.16M | -10.53M | -15.88M | -17.87M | 8.92M | -24.74M | -37.58M | -37.98M |
| Free Cash Flow | -11.81M | -14.21M | -18.79M | -12.57M | -12.04M | -14.81M | -16.34M | -23.17M | -17.71M | -26.86M | -37.58M | -38.23M |
| FCF Margin % | -5732.52% | -5550.78% | -19170.41% | -10479.17% | -7168.45% | -4046.17% | -7634.58% | -2099.09% | -3042.27% | -7144.41% | -11021.7% | -8364.55% |
| FCF Growth % | 1.94% | 4.04% | -14.99% | 45.74% | 31.98% | 44.87% | 56.53% | 39.38% | 66.18% | 30.48% | -20.52% | -15.41% |
| FCF per Share | -0.97 | -1.16 | -1.32 | -1.60 | -2.49 | -4.87 | -6.17 | -9.21 | -9.18 | -14.59 | -20.55 | -20.96 |
| FCF Conversion (FCF/Net Income) | 0.93x | 1.13x | 0.61x | 0.66x | 1.66x | 1.36x | 1.20x | 2.79x | 0.66x | 1.21x | 0.74x | 0.71x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |